|
1) Pytela R, Pierschbacher MD, Ruoslahti E. Identification and isolation of a 140 kD cell surface glycoprotein with properties expected of a fibronectin receptor. Cell. 1985; 40: 191-8
|
|
|
|
2) Sheppard D. Functions of pulmonary epithelial integrins: from development to disease. Physiol Rev. 2003; 83: 673-86
|
|
|
|
|
|
3) Somanath PR, Kandel ES, Hay N, et al. Akt1 signaling regulates integrin activation, matrix recognition, and fibronectin assembly. J Biol Chem. 2007; 282: 22964-76
|
|
|
|
|
|
4) Miyamoto S, Teramoto H, Gutkind JS, et al. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol. 1996; 135(6 Pt 1): 1633-42
|
|
|
|
|
|
5) Caswell PT, Norman JC. Integrin trafficking and the control of cell migration. Traffic. 2006; 7: 14-21
|
|
|
|
|
|
6) Mette SA, Pilewski J, Buck CA, et al. Distribution of integrin cell adhesion receptors on normal bronchial epithelial cells and lung cancer cells in vitro and in vivo. Am J Respir Cell Mol Biol. 1993; 8: 562-72
|
|
|
|
|
|
7) Barr LF, Campbell SE, Bochner BS, et al. Association of the decreased expression of alpha 3 beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells. Cancer Res. 1998; 58: 5537-45
|
|
|
|
|
|
8) Hodkinson PS, Mackinnon AC, Sethi T. Extracellular matrix regulation of drug resistance in small-cell lung cancer. Int J Radiat Biol. 2007; 83(11-12): 733-41
|
|
|
|
|
|
9) Nemerow GR, Pache L, Reddy V, et al. Insights into adenovirus host cell interactions from structural studies. Virology. 2009; 384: 380-8
|
|
|
|
|
|
10) Roger P, Puchelle E, Bajolet-lausinat O, et al. Fibronectin and alpha 5 beta1 integrin mediate binding of Pseudomonas aeruginosa to repairing airway epithelium. Eur Respir J. 1999; 13: 1301-9
|
|
|
|
|
|
11) Ganter MT, Roux J, Su G, et al. Role of small GTP-ases and alpha v beta 5 integrin in Pseudomonas aeruginosa-induced increase in lung endothelial permeability. Am J Respir Cell Mol Biol. 2009; 40: 108-18
|
|
|
|
|
|
12) Ghosh S, Chackerian AA, Parker CM, et al. The LFA-1 adhesion molecule is required for protective immunity during pulmonary Mycobacterium tuberculosis infection. J Immunol. 2006; 176: 4914-22
|
|
|
|
|
|
13) Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis)on chronic inflammatory lung disease. Chest. 2006; 129: 1673-82
|
|
|
|
|
|
14) Hanayama R, Tanaka M, Miwa K, et al. Identification of a factor that links apoptotic cells to phagocytes. Nature. 2002; 417: 182-7
|
|
|
|
|
|
15) Albert ML, Kim JI, Birge RB. alpha v beta 5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells. Nat Cell Biol. 2000; 2: 899-905
|
|
|
|
|
|
16) Kerksiek KM, Niedergang F, Chavrier P, et al. Selective Rac1 inhibition in dendritic cells diminishes apoptotic cell uptake and cross-presentation in vivo. Blood. 2005; 105: 742-9
|
|
|
|
|
|
17) Araya J, Nishimura SL. Fibrogenic reactions in lung disease. Annu Rev Pathol. 2010; 5: 77-98
|
|
|
|
|
|
18) Goodwin A, Jenkins G. Role of integrin-mediated TGF beta activation in the pathogenesis of pulmonary fibrosis. Biochem Soc Trans. 2009; 37: 849-54
|
|
|
|
|
|
19) Asano Y, Ihn H, Yamane K, et al. Increased expression of integrin αvβ3 contributes to the establishment of autocrine TGF-β signaling in scleroderma fibroblasts. J Immunol. 2005; 175; 7708-18
|
|
|
|
|
|
20) Yang Z, Mu Z, Dabovic B, et al. Absence of integrin-mediated TGF beta1 activation in vivo recapitulates the phenotype of TGF beta1-null mice. J Cell Biol. 2007; 176: 787-93
|
|
|
|
|
|
21) Aluwihare P, Mu Z, Zhao Z, et al. Mice that lack activity of alpha v beta 6- and alpha v beta 8-integrins reproduce the abnormalities of TGFβ1- and TGFβ3-null mice. J Cell Sci. 2009; 122(Pt 2): 227-32
|
|
|
|
|
|
22) Huang X, Wu J, Zhu W, et al. Expression of the human integrin beta 6 subunit in alveolar type II cells and bronchiolar epithelial cells reverses lung inflammation in beta 6 knockout mice. Am J Respir Cell Mol Biol. 1998; 19: 636-42
|
|
|
|
|
|
23) Munger JS, Huang X, Kawakatsu H, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999; 96(3): 319-28
|
|
|
|
|
|
24) Jenkins RG, Su X, Su G, et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta 6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest. 2006; 116: 1606-14
|
|
|
|
|
|
25) Puthawala K, Hadjiangelis N, Jacoby SC, et al. Inhibition of integrin alpha(v)beta 6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med. 2008; 177: 82-90
|
|
|
|
|
|
26) Morris DG, Huang X, Kaminski N, et al. Loss of integrin alpha(v)beta 6-mediated TGF beta activation causes Mmp12-dependent emphysema. Nature. 2003; 422: 169-73
|
|
|
|
|
|
27) Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A. 2006; 103: 13180-5
|
|
|
|
|
|
28) Horan GS, Wood S, Ona V, et al. Partial inhibition of integrin alpha(v)beta 6 prevents pulmonary fibrosis without exacerbating inflammation. Am J Respir Crit Care Med. 2008; 177: 56-65
|
|
|
|
|
|
29) Nishimura SL, Sheppard D, Pytela R. Integrin alpha v beta 8. Interaction with vitronectin and functional divergence of the beta 8 cytoplasmic domain. J Biol Chem. 1994; 269: 28708-15
|
|
|
|
|
|
30) Cambier S, Mu DZ, O'Connell D, et al. A role for the integrin alpha v beta 8 in the negative regulation of epithelial cell growth. Cancer Res. 2000; 60(24): 7084-93
|
|
|
|
|
|
31) Araya J, Cambier S, Morris A, et al. Integrin-mediated transforming growth factor-beta activation regulates homeostasis of the pulmonary epithelial-mesenchymal trophic unit. Am J Pathol. 2006; 169: 405-15
|
|
|
|
|
|
32) Mu D, Cambier S, Fjellbirkeland L, et al. The integrin alpha(v)beta 8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol. 2002; 157: 493-507
|
|
|
|
|
|
33) Nishimura SL. Integrin-mediated transforming growth factor-beta activation, a potential therapeutic target in fibrogenic disorders. Am J Pathol. 2009; 175: 1362-70
|
|
|
|
|
|
34) Neurohr C, Nishimura SL, Sheppard D. Activation of transforming growth factor-beta by the integrin alpha v beta 8 delays epithelial wound closure. Am J Respir Cell Mol Biol. 2006; 35(2): 252-9
|
|
|
|
|
|
35) Araya J, Cambier S, Markovics JA, et al. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. J Clin Invest. 2007; 117: 3551-62
|
|
|
|
|
|
36) Travis MA, Reizis B, Melton AC, et al. Loss of integrin alpha(v)beta 8 on dendritic cells causes autoimmunity and colitis in mice. Nature. 2007; 449(7160): 361-5
|
|
|
|
|
|
37) McNeel DG, Eickhoff J, Lee FT, et al. Phase I trial of a monoclonal antibody specific for alpha v beta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion. Clin Cancer Res. 2005; 11: 7851-60
|
|
|
|
|
|
38) Saadeh C, Saadeh C. Asthma remission in a patient with rheumatoid arthritis while on antiangiogenesis therapy during a rheumatoid arthritis trial demonstrated by forced oscillation and spirometry. J Asthma. 2007; 44: 281-3
|
|
|
|
|
|
39) Lee HS, Moon C, Lee HW, et al. Src tyrosine kinases mediate activations of NF-kappa B and integrin signal during lipopolysaccharide-induced acute lung injury. J Immunol. 2007; 179: 7001-11
|
|
|
|
|
|
40) Dekkers BG, Bos IS, Gosens R, et al. The integrin-blocking peptide RGDS inhibits airway smooth muscle remodeling in a guinea pig model of allergic asthma. Am J Respir Crit Care Med. 2010; 181: 556-65
|
|
|
|
|
|
41) Woodside DG, Vanderslice P. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease. BioDrugs. 2008; 22: 85-100
|
|
|
|
|
|
42) Clifford DB, De Luca A, Simpson DM, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol. 2010; 9: 438-46
|
|
|
|
|